Home | Archives | Products | About | Contact | FAQ |
New User? Sign Up | Sign In
Sec Filings Insider Trading - Beigene Ltd. (BGNE)
Select Time period:       google icon google     yahoo icon yahoo!
Send this page to:   blogger icon Blog    digg icon Digg    reddit icon Reddit    facebook icon Facebook    stumble icon Stumble    delicious icon del.icio.us

Enter Stock Ticker Symbol or Cik: SEC Cik Lookup Cik Lookup...

Search By Company or Insider Name: Powered by Google button
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch ==>> What is insider trading>>
BGNE Insider Trading Transactions for Beigene Ltd.
Historical filings delayed by 6 months. New user? Sign Up for real time data. Existing user? Sign In

Common stock purchase or sale:
Transaction
Date
Reported
Date
Company Symbol Insider
Relationship
Shares
Traded
Average
Price
Total
Amount
Shares
Owned
Filing
2016-11-23
Sale
2016-11-28
4:04 pm
Beigene Ltd. BGNE Wang Xiaodong
Director
93,750 $32 $3,000,000 15,125,393
(Direct
Indirect)
View
2016-11-23
Purchase
2016-11-28
4:02 pm
Beigene Ltd. BGNE Malley Thomas
Director
30,000 $32 $960,000 30,000
(Direct)
View
2016-11-18
Purchase
2016-11-21
6:13 pm
Beigene Ltd. BGNE Baker BROS. Advisors Lp
Baker Bros. Advisors (gp) LLC
Baker Julian
Baker Felix
667 L.P.
Baker Brothers Life Sciences Lp
14159 L.P.
Director
10% Owner
1,760,495 $32 $56,335,840 73,162,024
(Indirect)
View
2016-09-28
Sale
2016-09-30
4:50 pm
Beigene Ltd. BGNE Glazer Donald W.
Director
41,463 $30.66 $1,271,175 4,881,997
(Indirect
Direct)
View
2016-09-26
Sale
2016-09-28
4:11 pm
Beigene Ltd. BGNE Glazer Donald W.
Director
47,149 $29.61 $1,395,992 4,881,997
(Indirect
Direct)
View
2016-09-22
Sale
2016-09-26
6:12 pm
Beigene Ltd. BGNE Glazer Donald W.
Director
36,443 $31.02 $1,130,355 4,881,997
(Indirect
Direct)
View
2016-09-19
Sale
2016-09-21
9:11 pm
Beigene Ltd. BGNE Glazer Donald W.
Director
67,252 $31.42 $2,113,061 4,882,000
(Indirect
Direct)
View
2016-02-08
Purchase
2016-02-10
4:32 pm
Beigene Ltd. BGNE Hillhouse Capital Management Ltd.
10% Owner
9,100,000 $0 $0 39,726,780
(Indirect)
View
2016-02-08
Purchase
2016-02-09
8:08 pm
Beigene Ltd. BGNE Liang Howard
CFO & Chief Strategy Officer
65,000 $1.85 $120,250 65,000
(Direct)
View
2016-02-08
Purchase
2016-02-09
8:08 pm
Beigene Ltd. BGNE Yuan Ruirong
Chief Medical Officer
130,000 $1.85 $240,500 130,000
(Direct)
View
2016-02-08
Purchase
2016-02-09
5:38 pm
Beigene Ltd. BGNE Baker BROS. Advisors Lp
Baker Bros. Advisors (gp) LLC
Baker Julian
Baker Felix
667 L.P.
Baker Brothers Life Sciences Lp
14159 L.P.
Director
10% Owner
1,912,680 $24 $45,904,320 73,162,024
(Indirect)
View

Stock options: Exercise, Award, Grant, Conversion
Transaction
Date
Reported
Date
Exercisable
Expiration
Company Symnbol Insider
Relationship
Shares
Traded
Conversion
Price
Shares
Owned
Filing
2016-11-16
Option Award
2016-11-18
4:24 pm
N/A
2026-11-15
Beigene Ltd. BGNE Oyler John
Chief Executive Officer
Director
10% Owner
2,047,500 $2.84 2,047,500
(Direct)
View
2016-11-16
Option Award
2016-11-18
4:11 pm
N/A
2026-11-15
Beigene Ltd. BGNE Liang Howard
CFO & CSO
1,752,500 $2.84 1,752,500
(Direct)
View
2016-11-16
Option Award
2016-11-18
4:10 pm
N/A
2026-11-15
Beigene Ltd. BGNE Wang Xiaodong
Director
1,613,430 $2.84 1,613,430
(Direct)
View
2016-09-19
Gift
2016-09-21
9:11 pm
N/A
N/A
Beigene Ltd. BGNE Glazer Donald W.
Director
250,000 $0 4,882,000
(Direct)
View
2016-09-19
Gift
2016-09-21
9:11 pm
N/A
N/A
Beigene Ltd. BGNE Glazer Donald W.
Director
3 $0 4,882,000
(Direct)
View
2016-09-02
Option Award
2016-09-07
5:13 pm
N/A
N/A
Beigene Ltd. BGNE Huang Jane
CMO, Hematology
300,000 $0 1,400,000
(Direct)
View
2016-09-02
Option Award
2016-09-07
5:13 pm
N/A
2016-09-02
Beigene Ltd. BGNE Huang Jane
CMO, Hematology
1,400,000 $2.27 1,400,000
(Direct)
View
2016-08-22
Option Award
2016-08-24
6:12 pm
N/A
N/A
Beigene Ltd. BGNE Peterson Amy C.
CMO, Immuno-oncology
300,000 $0 1,600,000
(Direct)
View
2016-08-22
Option Award
2016-08-24
6:12 pm
N/A
2026-08-21
Beigene Ltd. BGNE Peterson Amy C.
CMO, Immuno-oncology
1,600,000 $2.24 1,600,000
(Direct)
View
2016-07-13
Option Award
2016-07-15
4:34 pm
N/A
2026-07-12
Beigene Ltd. BGNE Yang Jianxin
Sr. VP, Head of Clinical Dev.
825,000 $2.29 825,000
(Direct)
View
2016-07-13
Option Award
2016-07-15
4:32 pm
N/A
2026-07-12
Beigene Ltd. BGNE Li Ji
EVP and Gl. Head of Bus. Dev.
260,000 $2.29 260,000
(Direct)
View
2016-07-13
Option Award
2016-07-15
4:30 pm
N/A
2026-07-12
Beigene Ltd. BGNE Yan Wendy Xiaojun
Sr. VP, Head of Reg. Affairs
825,000 $2.29 825,000
(Direct)
View
2016-05-03
Option Award
2016-05-05
4:36 pm
N/A
N/A
Beigene Ltd. BGNE Li Ji
EVP and Gl. Head of Bus. Dev.
475,000 $0 2,376,000
(Direct)
View
2016-05-03
Option Award
2016-05-05
4:36 pm
N/A
2026-05-02
Beigene Ltd. BGNE Li Ji
EVP and Gl. Head of Bus. Dev.
2,376,000 $2.05 2,376,000
(Direct)
View
2016-02-08
Conversion
2016-02-10
4:32 pm
N/A
N/A
Beigene Ltd. BGNE Hillhouse Capital Management Ltd.
10% Owner
30,626,780 $0 39,726,780
(Indirect)
View
2016-02-08
Conversion
2016-02-10
4:32 pm
N/A
N/A
Beigene Ltd. BGNE Hillhouse Capital Management Ltd.
10% Owner
14,814,814 $0 39,726,780
(Indirect)
View
2016-02-08
Conversion
2016-02-10
4:32 pm
N/A
N/A
Beigene Ltd. BGNE Hillhouse Capital Management Ltd.
10% Owner
15,811,965 $0 39,726,780
(Indirect)
View
2016-02-08
Conversion
2016-02-10
4:28 pm
N/A
N/A
Beigene Ltd. BGNE Merck & Co. Inc.
Merck Sharp & Dohme Corp.
Merck Sharp & Dohme Research Gmbh
10% Owner
18,518,520 $0 18,518,520
(Indirect)
View
2016-02-08
Conversion
2016-02-10
4:28 pm
N/A
N/A
Beigene Ltd. BGNE Merck & Co. Inc.
Merck Sharp & Dohme Corp.
Merck Sharp & Dohme Research Gmbh
10% Owner
5,128,205 $0 18,518,520
(Indirect)
View
2016-02-08
Other
2016-02-10
4:28 pm
N/A
N/A
Beigene Ltd. BGNE Merck & Co. Inc.
Merck Sharp & Dohme Corp.
Merck Sharp & Dohme Research Gmbh
10% Owner
7,942,314 $0 18,518,520
(Indirect)
View
2016-02-08
Conversion
2016-02-10
4:28 pm
N/A
N/A
Beigene Ltd. BGNE Merck & Co. Inc.
Merck Sharp & Dohme Corp.
Merck Sharp & Dohme Research Gmbh
10% Owner
18,518,520 $0 18,518,520
(Indirect)
View
2016-02-08
Conversion
2016-02-10
4:28 pm
N/A
N/A
Beigene Ltd. BGNE Merck & Co. Inc.
Merck Sharp & Dohme Corp.
Merck Sharp & Dohme Research Gmbh
10% Owner
5,128,205 $0 18,518,520
(Indirect)
View
2016-02-08
Conversion
2016-02-09
8:58 pm
N/A
N/A
Beigene Ltd. BGNE Oyler John
CEO
Director
10% Owner
9,398,380 $0 59,780,348
(Direct)
View
2016-02-08
Exercise
2016-02-09
8:58 pm
2014-10-07
N/A
Beigene Ltd. BGNE Oyler John
CEO
Director
10% Owner
57,777 $0.675 59,780,348
(Direct)
View
2016-02-08
Exercise
2016-02-09
8:58 pm
N/A
N/A
Beigene Ltd. BGNE Oyler John
CEO
Director
10% Owner
57,777 $0 59,780,348
(Direct)
View
2016-02-08
Conversion
2016-02-09
8:58 pm
N/A
N/A
Beigene Ltd. BGNE Oyler John
CEO
Director
10% Owner
9,398,380 $0 59,780,348
(Direct)
View
2016-02-08
Option Award
2016-02-09
8:09 pm
N/A
2026-02-08
Beigene Ltd. BGNE Chen Timothy Yung-cheng
Director
460,626 $2.43 460,626
(Direct)
View
2016-02-08
Conversion
2016-02-09
8:07 pm
N/A
N/A
Beigene Ltd. BGNE Cb Biotech Investment Ltd
Cpechina Fund L.P.
Citic Pe Associates L.P.
Citic Pe Funds Ltd
10% Owner
19,601,138 $0 19,601,138
(Direct)
View
2016-02-08
Conversion
2016-02-09
8:07 pm
N/A
N/A
Beigene Ltd. BGNE Cb Biotech Investment Ltd
Cpechina Fund L.P.
Citic Pe Associates L.P.
Citic Pe Funds Ltd
10% Owner
14,814,814 $0 19,601,138
(Direct)
View
2016-02-08
Conversion
2016-02-09
8:07 pm
N/A
N/A
Beigene Ltd. BGNE Cb Biotech Investment Ltd
Cpechina Fund L.P.
Citic Pe Associates L.P.
Citic Pe Funds Ltd
10% Owner
4,786,324 $0 19,601,138
(Direct)
View
2016-02-08
Conversion
2016-02-09
5:38 pm
N/A
N/A
Beigene Ltd. BGNE Baker BROS. Advisors Lp
Baker Bros. Advisors (gp) LLC
Baker Julian
Baker Felix
667 L.P.
Baker Brothers Life Sciences Lp
14159 L.P.
Director
10% Owner
4,382,118 $0 73,162,024
(Indirect)
View
2016-02-08
Conversion
2016-02-09
5:38 pm
N/A
N/A
Beigene Ltd. BGNE Baker BROS. Advisors Lp
Baker Bros. Advisors (gp) LLC
Baker Julian
Baker Felix
667 L.P.
Baker Brothers Life Sciences Lp
14159 L.P.
Director
10% Owner
44,572,172 $0 73,162,024
(Indirect)
View
2016-02-08
Conversion
2016-02-09
5:38 pm
N/A
N/A
Beigene Ltd. BGNE Baker BROS. Advisors Lp
Baker Bros. Advisors (gp) LLC
Baker Julian
Baker Felix
667 L.P.
Baker Brothers Life Sciences Lp
14159 L.P.
Director
10% Owner
582,747 $0 73,162,024
(Indirect)
View
2016-02-08
Conversion
2016-02-09
5:38 pm
N/A
N/A
Beigene Ltd. BGNE Baker BROS. Advisors Lp
Baker Bros. Advisors (gp) LLC
Baker Julian
Baker Felix
667 L.P.
Baker Brothers Life Sciences Lp
14159 L.P.
Director
10% Owner
1,912,167 $0 73,162,024
(Indirect)
View
2016-02-08
Conversion
2016-02-09
5:38 pm
N/A
N/A
Beigene Ltd. BGNE Baker BROS. Advisors Lp
Baker Bros. Advisors (gp) LLC
Baker Julian
Baker Felix
667 L.P.
Baker Brothers Life Sciences Lp
14159 L.P.
Director
10% Owner
26,292,960 $0 73,162,024
(Indirect)
View
2016-02-08
Exercise
2016-02-09
5:38 pm
N/A
N/A
Beigene Ltd. BGNE Baker BROS. Advisors Lp
Baker Bros. Advisors (gp) LLC
Baker Julian
Baker Felix
667 L.P.
Baker Brothers Life Sciences Lp
14159 L.P.
Director
10% Owner
238,850 $0.675 73,162,024
(Indirect)
View
2016-02-08
Exercise
2016-02-09
5:38 pm
N/A
N/A
Beigene Ltd. BGNE Baker BROS. Advisors Lp
Baker Bros. Advisors (gp) LLC
Baker Julian
Baker Felix
667 L.P.
Baker Brothers Life Sciences Lp
14159 L.P.
Director
10% Owner
2,296,890 $0.675 73,162,024
(Indirect)
View
2016-02-08
Exercise
2016-02-09
5:38 pm
N/A
N/A
Beigene Ltd. BGNE Baker BROS. Advisors Lp
Baker Bros. Advisors (gp) LLC
Baker Julian
Baker Felix
667 L.P.
Baker Brothers Life Sciences Lp
14159 L.P.
Director
10% Owner
56,853 $0.675 73,162,024
(Indirect)
View
2016-02-08
Conversion
2016-02-09
5:38 pm
N/A
N/A
Beigene Ltd. BGNE Baker BROS. Advisors Lp
Baker Bros. Advisors (gp) LLC
Baker Julian
Baker Felix
667 L.P.
Baker Brothers Life Sciences Lp
14159 L.P.
Director
10% Owner
4,382,118 $0 73,162,024
(Indirect)
View
2016-02-08
Conversion
2016-02-09
5:38 pm
N/A
N/A
Beigene Ltd. BGNE Baker BROS. Advisors Lp
Baker Bros. Advisors (gp) LLC
Baker Julian
Baker Felix
667 L.P.
Baker Brothers Life Sciences Lp
14159 L.P.
Director
10% Owner
44,572,172 $0 73,162,024
(Indirect)
View
2016-02-08
Conversion
2016-02-09
5:38 pm
N/A
N/A
Beigene Ltd. BGNE Baker BROS. Advisors Lp
Baker Bros. Advisors (gp) LLC
Baker Julian
Baker Felix
667 L.P.
Baker Brothers Life Sciences Lp
14159 L.P.
Director
10% Owner
582,747 $0 73,162,024
(Indirect)
View
2016-02-08
Conversion
2016-02-09
5:38 pm
N/A
N/A
Beigene Ltd. BGNE Baker BROS. Advisors Lp
Baker Bros. Advisors (gp) LLC
Baker Julian
Baker Felix
667 L.P.
Baker Brothers Life Sciences Lp
14159 L.P.
Director
10% Owner
1,912,167 $0 73,162,024
(Indirect)
View
2016-02-08
Conversion
2016-02-09
5:38 pm
N/A
N/A
Beigene Ltd. BGNE Baker BROS. Advisors Lp
Baker Bros. Advisors (gp) LLC
Baker Julian
Baker Felix
667 L.P.
Baker Brothers Life Sciences Lp
14159 L.P.
Director
10% Owner
26,292,960 $0 73,162,024
(Indirect)
View
2016-02-08
Exercise
2016-02-09
5:38 pm
2014-08-12
2019-08-12
Beigene Ltd. BGNE Baker BROS. Advisors Lp
Baker Bros. Advisors (gp) LLC
Baker Julian
Baker Felix
667 L.P.
Baker Brothers Life Sciences Lp
14159 L.P.
Director
10% Owner
238,850 $0.675 73,162,024
(Indirect)
View
2016-02-08
Exercise
2016-02-09
5:38 pm
2014-08-12
2019-08-12
Beigene Ltd. BGNE Baker BROS. Advisors Lp
Baker Bros. Advisors (gp) LLC
Baker Julian
Baker Felix
667 L.P.
Baker Brothers Life Sciences Lp
14159 L.P.
Director
10% Owner
2,296,890 $0.675 73,162,024
(Indirect)
View
2016-02-08
Exercise
2016-02-09
5:38 pm
2014-08-12
2019-08-12
Beigene Ltd. BGNE Baker BROS. Advisors Lp
Baker Bros. Advisors (gp) LLC
Baker Julian
Baker Felix
667 L.P.
Baker Brothers Life Sciences Lp
14159 L.P.
Director
10% Owner
56,853 $0.675 73,162,024
(Indirect)
View